Prolight Diagnostics AB (publ) (NGM:PRLD)

Market Cap	177.63M
Revenue (ttm)	37.40M
Net Income (ttm)	-28.95M
Shares Out	702.09M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,754,012
Average Volume	4,647,467
Open	n/a
Previous Close	0.2470
Day's Range	n/a
52-Week Range	0.1181 - 0.8092
Beta	2.69
RSI	48.58
Earnings Date	Aug 28, 2025

About Prolight Diagnostics AB

Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing in Sweden. It engages in the development of PLD micro flex and flex membrane. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Stockholm, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 16
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: PRLD

Financial Performance

In 2024, Prolight Diagnostics AB's revenue was 36.37 million, an increase of 50.18% compared to the previous year's 24.22 million. Losses were -26.94 million, -80.11% less than in 2023.